文献速递头颈外科

头颈癌患者医疗质量中的保险差异

Insurance Disparities in Quality of Care Among Patients With Head and Neck Cancer.
PubMed 文献 · JAMA Otolaryngol Head Neck Surg · 2024-01-01

这项回顾性队列研究纳入加州癌症登记库2010年1月1日至2019年12月31日诊断的23,933例成人头颈癌患者,评估保险状态与就诊医院质量、指南依从性治疗及总生存的关联。Medicare、Medicaid和无保险状态与接受高质量医院治疗的可能性较低相关,晚期患者中Medicaid和无保险者接受双模式治疗的可能性较低,Medicaid患者接受辅助放疗的可能性较低。

要点

  • Medicare、Medicaid和无保险状态与商业保险相比,在高治疗质量医院就诊的可能性较低。
  • 晚期患者中,Medicaid和无保险患者接受双模式治疗的可能性较低。
  • 手术切除的晚期患者中,Medicaid保险与接受辅助放疗的可能性较低相关。

核心结论

  • 本研究发现头颈癌患者医疗质量存在显著的保险差异,凸显美国持续医保改革的必要性,以在扩大保险覆盖的同时提升保险质量。

研究设计与样本

  • 回顾性队列研究,数据来自加州癌症登记库,链接出院记录和加州健康可及与信息部医院特征数据。
  • 纳入2010年1月1日至2019年12月31日诊断的成人头颈癌患者,共23,933例,平均(标准差)年龄64.8(12.3)岁,男性占75.3%。
  • 数据分析时间为2023年5月10日至2024年3月25日。

主要发现

  • 与在最低三分位医院治疗相比,在最高三分位医院治疗与总生存改善相关(风险比,0.87;95% CI,0.79-0.95)。
  • 与商业保险相比,Medicare(比值比[OR],0.78;95% CI,0.73-0.84)、Medicaid(OR,0.60;95% CI,0.54-0.66)和无保险(OR,0.38;95% CI,0.29-0.49)状态与在高治疗质量医院就诊的可能性较低相关。
  • 在晚期疾病患者中,Medicaid(OR,0.72;95% CI,0.62-0.83)和无保险(OR,0.64;95% CI,0.44-0.93)患者接受双模式治疗的可能性较低。
  • 在手术切除的晚期疾病患者中,Medicaid保险(OR,0.73;95% CI,0.58-0.93)与接受辅助放疗的可能性较低相关。

关键数值与推荐

  • 主要结局为就诊医院质量(三分位)、接受美国国家综合癌症网络指南依从性治疗及总生存。
  • 保险状态暴露分类为商业保险、Medicare、Medicaid、无保险、其他或未知。

临床怎么用

  • 原文未据此给出推荐。

局限性

  • 原文未报告局限性。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

IMPORTANCE: Significant insurance status disparities have been demonstrated in head and neck cancer (HNC) outcomes. The effects of insurance status on HNC outcomes may be explained by differential access to high-quality care. OBJECTIVE: To evaluate the association of insurance status with the quality of the treating hospital and receipt of guideline-compliant care among patients with HNC. DESIGN, SETTING, AND PARTICIPANTS: This retrospective cohort study of data from the California Cancer Registry dataset linked with discharge records and hospital characteristics from the California Department of Health Care Access and Information included adult patients with HNC diagnosed between January 1, 2010, and December 31, 2019. Data were analyzed from May 10, 2023, to March 25, 2024. EXPOSURES: Insurance status: commercial, Medicare, Medicaid, uninsured, other, or unknown. MAIN OUTCOMES AND MEASURES: Quality of the treating hospital (tertiles), receipt of National Comprehensive Cancer Network guideline-compliant care, and overall survival. RESULTS: A total of 23 933 patients (mean [SD] age, 64.8 [12.3] years; 75.3% male) met the inclusion criteria. Treatment in top-tertile hospitals (hazard ratio, 0.87; 95% CI, 0.79-0.95) was associated with improved overall survival compared with treatment in bottom-tertile hospitals. Medicare (odds ratio [OR], 0.78; 95% CI, 0.73-0.84), Medicaid (OR, 0.60; 95% CI, 0.54-0.66), and uninsured (OR, 0.38; 95% CI, 0.29-0.49) status were associated with lower likelihood of treatment in high-quality hospitals compared with commercial insurance. Among patients with advanced disease, Medicaid (OR, 0.72; 95% CI, 0.62-0.83) and uninsured (OR, 0.64; 95% CI, 0.44-0.93) patients were less likely to receive dual-modality therapy. Among patients with surgically resected advanced disease, Medicaid coverage (OR, 0.73; 95% CI, 0.58-0.93) was associated with lower likelihood of receiving adjuvant radiotherapy. CONCLUSIONS AND RELEVANCE: This study found significant insurance disparities in quality of care among patients with HNC. These findings highlight the need for continued health insurance reform in the US to improve the quality of insurance coverage, in addition to expanding access to health insurance.

来源:JAMA Otolaryngol Head Neck Surg,查看原文。版权归原作者所有。

引用

  1. Megwalu UC, Ma Y, Divi V, et al. Insurance Disparities in Quality of Care Among Patients With Head and Neck Cancer. JAMA Otolaryngol Head Neck Surg. 2024. PMID: 38869878. doi:10.1001/jamaoto.2024.1338

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。